Press release - 31/03/2014 Universal Biotech: Call for Proposals for the 6. Innovation Prize 2014 The Innovation Prize 2014 aims to promote innovation in the field of biotechnology. It targets medicines, medical devices, medical technologies and e-health solutions. The Innovation Prize is open to Academic researchers in the field of Life Sciences and Representatives from young companies. The winner will receive a reward of a combined value of 50,000€ including cash and consulting services provided by Universal Biotech during one year after…https://www.gesundheitsindustrie-bw.de/en/article/press-release/universal-biotech-call-for-proposals-for-the-6-innovation-prize-2014
Article - 10/03/2014 INCIDE – IT solutions in the life sciences The use of modern research methods in the natural sciences generates increasing amounts of data, which can often only be analysed using special software. The INCIDE research centre at the University of Konstanz provides data processing services that facilitate the development and adaptation of software programmes for use in the life sciences. The INCIDE scientists work in close collaboration with life scientists. In future, this successful…https://www.gesundheitsindustrie-bw.de/en/article/news/incide-it-solutions-in-the-life-sciences
Guest article - 31/01/2014 Experience report: internship at Boehringer Ingelheim in Shanghai A scholarship from the Baden-Württemberg Ministry of Science, Research and the Arts enabled Henrik Baran to do an internship at Boehringer Ingelheim Pharma GmbH and Co. KG in Shanghai. From March to August 2013, Henrik worked in the company's Global Biopharma Engineering & Technology department where he was involved in cleanroom planning. He was also project coordinator in charge of redeveloping company premises. Here he summarises his…https://www.gesundheitsindustrie-bw.de/en/article/news/experience-report-internship-at-boehringer-ingelheim-in-shanghai
Press release - 15/01/2014 Hit Discovery Constance GmbH: a new hub for HTS and compound management Hit Discovery Constance GmbH (“HDC”), a new joint venture organisation between Lead Discovery Center (Dortmund/Germany), Centre for Drug Design and Discovery (CD3, KULeuven, Leuven/Belgium) and Axxam (Milan/Italy) has started its operation. The new company is based in Constance (Germany) and will make use of the already established equipment and know-how of the former Takeda/Nycomed/Altana screening and compound management facilities at the site.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hit-discovery-constance-gmbh-a-new-hub-for-hts-and-compound-management
Article - 09/12/2013 KVART – a hospital bed with built-in intelligence Exercise is the best medicine! this was the maxim adopted by Dr. Clemens Gutknecht and Dr. Josef Schönberger when they were investigating the treatment remobilisation and care of bedridden patients. The findings of the two experienced neurologists led to the development of a concept for an intelligent hospital bed. Based on a patented technology and quantitative market potential estimates Gutknecht and Schönberger have established KVART GmbH in…https://www.gesundheitsindustrie-bw.de/en/article/news/kvart-a-hospital-bed-with-built-in-intelligence
Article - 25/11/2013 GlucoChat: a communication platform for the treatment of young patients with type I diabetes The idea of being able to access a secure and relatively straightforward way of communicating with others as part of a social network definitely appeals to those who live several hundred kilometres away from a specialist doctor. However, data protection issues present a number of difficulties. careon, an e-health company from Tübingen, has found a solution by developing a platform for social network applications in which data remains…https://www.gesundheitsindustrie-bw.de/en/article/news/glucochat-a-communication-platform-for-the-treatment-of-young-patients-with-type-i-diabetes
Press release - 20/11/2013 State affiliate BIOPRO Baden-Württemberg supports the local medical engineering industry State affiliate BIOPRO Baden-Württemberg, an agency focussing on medical engineering, biotechnology and pharmaceuticals in Baden-Württemberg, presents itself at MEDICA. Find us at the Baden-Württemberg joint booth (hall 16 C41) to obtain information about our region. The recently published industry report “Healthcare Industry 2013, Facts and Figures for Baden-Württemberg” containing current data on medical engineering as well as a biotech guide…https://www.gesundheitsindustrie-bw.de/en/article/press-release/state-affiliate-biopro-baden-wuerttemberg-supports-the-local-medical-engineering-industry
Article - 18/11/2013 Insilico Biotechnology AG: strategic orientation secures corporate growth Insilico Biotechnology AG from Stuttgart designs and optimises biotechnological processes for the chemical pharmaceutical and food industries. The company makes predictions on the behaviour of cells and organisms. This knowledge can be used to reduce the time required for the development or optimisation of biotechnological processes involving the production of drugs. The company owns a worldwide unique systems biology platform that integrates…https://www.gesundheitsindustrie-bw.de/en/article/news/insilico-biotechnology-ag-strategic-orientation-secures-corporate-growth
Article - 18/11/2013 The HAE Accelerator – "compete to speed up your start-up" The HAE Accelerator is an international programme involving biomedical clusters in Cambridge (UK), Leuven (Belgium) and Heidelberg (Germany) that seeks to identify, train and put innovative start-up teams in the three countries in contact with international VC investors. Of the three business ideas that were awarded a HAE Investors’ Choice Award in September 2013, InoCard from Heidelberg came first with a new gene therapy for myocardial…https://www.gesundheitsindustrie-bw.de/en/article/news/the-hae-accelerator-compete-to-speed-up-your-start-up
Article - 11/11/2013 Vitaphone GmbH - innovative telemedicine Vitaphone GmbH from Mannheim is a leading international telemedical service provider. Its services range from telecardiological functional diagnostics, 24/7 telemonitoring of risk patients to integrative care management of chronically ill patients. Vitaphone is particularly involved in the application of structured telemonitoring-based therapy programmes for patients with heart failure. https://www.gesundheitsindustrie-bw.de/en/article/news/vitaphone-gmbh-innovative-telemedicine
Press release - 16/10/2013 BIOTECHNICA 2013 - Baden-Württemberg is a top life sciences spot. The BIOTECHNICA trade show rolled out the red carpet for its exhibitors. Over 10,000 visitors walked over the carpet to inspect the exhibits that were on display at the Baden-Württemberg booth. The impressive exhibits of the companies showed that Baden-Württemberg has many highly innovative SMEs in the life sciences field. https://www.gesundheitsindustrie-bw.de/en/article/news/biotechnica-2013-baden-wuerttemberg-is-a-top-life-sciences-spot
Article - 16/09/2013 Infrared light as an indicator of wine quality Guaranteeing the quality of wines is becoming increasingly important so that they are able to compete in the international market. However, the quality control methods currently used are often rather time-consuming and costly. In addition, it is difficult to detect microbial grape contaminations that might jeopardise the quality of the wines. Researchers at the National Training and Research Institute for Viticulture and Horticulture in…https://www.gesundheitsindustrie-bw.de/en/article/news/infrared-light-as-an-indicator-of-wine-quality
Article - 19/08/2013 Fraunhofer IPA – mobile emergency assistant prepares for the marketplace The Fraunhofer Institute for Manufacturing Engineering and Automation IPA has developed MobiNa a mobile emergency assistant to deliver external support to elderly and infirm people. MobiNa will enable them to stay in their own homes as long as possible where they can lead an independent life. MobiNa assists its owner not only as a reliable helper in emergency situations but also as a continuously-available mobile communication system.https://www.gesundheitsindustrie-bw.de/en/article/news/fraunhofer-ipa-mobile-emergency-assistant-prepares-for-the-marketplace
Dossier - 19/08/2013 Telemedicine: advances in high-tech healthcare Increasing average longevity, the growing number of chronic diseases and health economy issues are all generating an ever-increasing demand for inexpensive therapy options that are not time- or location dependent. For the past 10 years or so, telemedicine has been offering advanced solutions for a broad range of medical and health issues. Despite this progress, the use of telecommunication and information technologies in the provision of remote…https://www.gesundheitsindustrie-bw.de/en/article/dossier/telemedicine-advances-in-high-tech-healthcare
Article - 12/08/2013 A complete exome sequence in one week The exome is the part of the genome that is formed by exons i.e. the DNA regions that code for proteins and other functional products. Though comprising only about 1 of the total genome the majority of disease-causing mutations occur in the exome. Selectively sequencing the coding regions of the genome is quicker than whole-genome sequencing. Therefore exome sequencing plays an important role in the diagnosis of genetic diseases and cancer.…https://www.gesundheitsindustrie-bw.de/en/article/news/a-complete-exome-sequence-in-one-week
Article - 07/08/2013 New regulations covering the use of laboratory animals The new directive of the European Parliament and of the Council on the protection of animals used for scientific purposes was adopted on 22nd September 2010 and was implemented into the German Animal Welfare Act which came into force in February 2013. These regulations have implications for companies and researchers alike. In recent years a growing number of alternative methods to animal testing have been developed. Dr. Nina Hasiwa CEO of…https://www.gesundheitsindustrie-bw.de/en/article/news/new-regulations-covering-the-use-of-laboratory-animals
Press release - 05/08/2013 greenovation Biotech GmbH – production of therapeutic proteins in moss Plants can be genetically modified in a way that enables them to produce pharmaceutically active proteins for various indications. The small moss Physcomitrella patens is able to produce more complex molecules than bacteria. Moreover, moss is less expensive to grow and less susceptible to pathogenic contaminants than Chinese hamster ovary (CHO) cells. greenovation Biotech GmbH, which has its headquarters in Heilbronn and a branch in Freiburg,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/greenovation-biotech-gmbh-production-of-therapeutic-proteins-in-moss
Article - 22/07/2013 FESTO – tapping into the bioproduction market Festo AG Co. KG is a leading provider of factory automation and process automation. The company has been involved in and contributed to shaping the development of such automation solutions ever since its foundation in 1925. Festo markets electrical and pneumatic drive technology valves sensors and other automation components as well as complete control units. Moreover when industrial bioproduction involving living microorganisms was gaining in…https://www.gesundheitsindustrie-bw.de/en/article/news/festo-tapping-into-the-bioproduction-market
Article - 21/05/2013 Green gold: bioactive plant foods Nowadays everything must be good for something must have a direct noticeable or tangible effect. The ever topical issue of nutrition is no exception. All this makes functional food a promising and inexhaustible market. Teams of scientists around the world are focussing on how unhealthy food can be made healthy. Bioactive plant foods are expected to close a gap that should not have existed in the first place. https://www.gesundheitsindustrie-bw.de/en/article/news/green-gold-bioactive-plant-foods
Article - 09/05/2013 Immunoproteasome Drug Targeting: Immunoproteasome inhibitors allow control of autoimmune diseases Marcus Groettrup is the chair of immunology at the University of Konstanz and has been active in the field of immunology for many years. In 2009 Groettrup made a discovery that led to him setting up a company. His analysis of immunoproteasomes whose main function is to degrade unneeded or damaged proteins showed that these protein complexes also play a major role in the development of autoimmune diseases. Based on this knowledge Groettrup…https://www.gesundheitsindustrie-bw.de/en/article/news/immunoproteasome-drug-targeting-immunoproteasome-inhibitors-allow-control-of-autoimmune-diseases
Press release - 30/04/2013 Impressions from the 2013 BIO International Convention in Chicago A trade fair turns 20 and an industrial sector is coming of age. Where does BIO stand today? The number of exhibitors has slightly decreased the conference is characterised by general themes and trends and partnering has become the most important and indispensable part of the global event for biotechnology. What was once a gold rush atmosphere has given way to an experienced self-confidence about the economic importance of biotechnology. https://www.gesundheitsindustrie-bw.de/en/article/press-release/impressions-from-the-2013-bio-international-convention-in-chicago
Article - 29/04/2013 ‘Autotech meets Biotech’ – current status and outlook Intensive cooperation between the engineering-driven sectors and the biotechnology sector is a prerequisite for driving forward automation in the field of biotechnology. The Engineering – Life Sciences – Automation (ELSA) cluster initiative of BioRegio STERN Management GmbH aims to promote cross-industry cooperation. A study entitled ‘Biotech meets Autotech’, which was carried out as part of the ELSA project, provides insights into the current…https://www.gesundheitsindustrie-bw.de/en/article/news/autotech-meets-biotech-current-status-and-outlook
Article - 22/04/2013 HB Technologies AG - the automated research laboratory Automated solutions for research and development have to fulfil special requirements; rather than being directed towards mass production, they need to be able to handle highly complex processes and minute amounts of sample. HB Technologies AG specifically focuses on this market, offering engineering services and products for use in the field of biotechnology.https://www.gesundheitsindustrie-bw.de/en/article/news/hb-technologies-ag-the-automated-research-laboratory
Article - 12/03/2013 Science to business – exit strategies for biotech companies The two directors of the consultancy firm LSCN Ltd. Dr. Alrik Koppenhöfer and Dr. Volker Ungermann explain the key issues involved in MA negotiations and licensing deals and how LSCN supports biotechnology companies and strategic investors in reaching their goals. Both managers agree that a good dose of realism is necessary. https://www.gesundheitsindustrie-bw.de/en/article/news/science-to-business-exit-strategies-for-biotech-companies
Article - 11/03/2013 Trenzyme – optimal expression of recombinant proteins Trenzyme GmbH in Konstanz offers services and products in the fields of genomics and proteomics. The company specialises in contract research and custom R&D services and is also working on new and improved products and processes. The company recently developed a new method for the rapid identification of optimal expression conditions for recombinant proteins. https://www.gesundheitsindustrie-bw.de/en/article/news/trenzyme-optimal-expression-of-recombinant-proteins